Box score
Eupraxia Pharmaceuticals Inc.
Reported $1.9M sold in a new Form D filed November 8, 2024 (Victoria, outside the US).
- Biggest raise
- $1.9M filed Nov 8, 2024
- League
- Bio & Health Biotechnology
- Based in
- Victoria, outside the US
- Season rank
- #796 of 1,389 in the Bio & Health League; #5704 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-11-08 | New notice | $1.9M | $1.9M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1581178.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | ImmunoPrecise Antibodies Ltd. | Bio & Health | $2M |
| 2 | Alpha Cognition Inc. | Bio & Health | $1.8M |
| 3 | NLS Pharmaceutics Ltd. | Bio & Health | $1.8M |
| 4 | Scinai Immunotherapeutics Ltd. | Bio & Health | $1.7M |
| 5 | Voxcell BioInnovation Inc. rookie | Bio & Health | $1.5M |
| 6 | Analytics for Life Inc. | Bio & Health | $1.5M |